Evolent Health Inc - Class A

EVH NYSE Healthcare & Biotech United States US30050B1017
3.95 $
2.86 %

Evolent Health is an American company that provides integrated healthcare services and software solutions to help health systems improve clinical and financial outcomes.

Price history of Evolent Health Inc - Class A
Price history of Evolent Health Inc - Class A

Performance & Momentum

6 Months 7.49 %
1 Year 45.21 %
3 Years 87.63 %
5 Years 79.67 %

Strategic Analysis

Evolent Health Inc - Class A • 2026

Evolent Health positions itself as an integrated healthcare services provider and software company offering clinical and financial management support to U.S. health systems. Its appeal lies in a specialized B2B proposition at the intersection of healthcare and technology, aimed at improving care delivery and cost control in complex environments.

Strengths
  • Niche positioning focused on optimizing care pathways and the financial performance of hospitals and health networks
  • Hybrid model combining healthcare operational expertise and software solutions
  • Exposure to a market with structural demand for efficiency tools in a healthcare system under pressure
Weaknesses
  • Very poor stock performance, reflecting a loss of market confidence
  • High sensitivity to commercial execution and profitability in a competitive sector
  • Financial visibility weakened by persistently poor long-term performance
Momentum

Momentum is extremely weak and the share price trend remains clearly bearish across all observed timeframes. In the absence of any identifiable recent catalyst, the stock appears to be more of a speculative turnaround situation than a momentum play, with a high-risk profile for retail investors.

Similar stocks to Evolent Health Inc - Class A

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone